DK0598719T3 - Receptorkonjugater til destinering af lægemidler og andre midler - Google Patents
Receptorkonjugater til destinering af lægemidler og andre midlerInfo
- Publication number
- DK0598719T3 DK0598719T3 DK91915386T DK91915386T DK0598719T3 DK 0598719 T3 DK0598719 T3 DK 0598719T3 DK 91915386 T DK91915386 T DK 91915386T DK 91915386 T DK91915386 T DK 91915386T DK 0598719 T3 DK0598719 T3 DK 0598719T3
- Authority
- DK
- Denmark
- Prior art keywords
- agents
- drugs
- destination
- conjugates
- receptor conjugates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6425—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002114629A CA2114629C (en) | 1991-07-31 | 1991-07-31 | Receptor conjugates for targeting antibiotics to bacteria |
PCT/US1991/005422 WO1993002709A1 (en) | 1991-07-31 | 1991-07-31 | Receptor conjugates for targeting drugs and other agents |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0598719T3 true DK0598719T3 (da) | 1999-06-14 |
Family
ID=25676975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91915386T DK0598719T3 (da) | 1991-07-31 | 1991-07-31 | Receptorkonjugater til destinering af lægemidler og andre midler |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0598719B1 (ja) |
JP (1) | JP3369555B2 (ja) |
AT (1) | ATE171072T1 (ja) |
CA (1) | CA2114629C (ja) |
DE (1) | DE69130235T2 (ja) |
DK (1) | DK0598719T3 (ja) |
ES (1) | ES2123514T3 (ja) |
WO (1) | WO1993002709A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7097839B1 (en) | 1993-10-26 | 2006-08-29 | Thomas Jefferson University | ST receptor binding compounds and methods of using the same |
JPH08133971A (ja) * | 1994-09-16 | 1996-05-28 | Toyama Chem Co Ltd | 抗ヘリコバクター剤 |
CA2253204A1 (en) * | 1996-05-03 | 1997-11-13 | Roger S. Cubicciotti | Prodrug compositions and drug delivery methods using synthetic receptors |
JP7534796B2 (ja) * | 2019-01-08 | 2024-08-15 | ユニバーシティー オブ ジョージア リサーチ ファウンデーション, インコーポレイテッド | 標的化ナノ粒子、及び真菌感染に関連するそれらの使用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1165238A (en) * | 1980-03-12 | 1984-04-10 | Demetrios P. Papahadjopoulos | Activated liposomes and method |
SE8501613D0 (sv) * | 1985-04-01 | 1985-04-01 | Bio Carb Ab | Foreningar for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling |
GB8628398D0 (en) * | 1986-11-27 | 1986-12-31 | Central Blood Lab Authority | Pharmaceutically-active conjugates |
DE3711724A1 (de) * | 1987-04-07 | 1988-10-20 | Harro Boerner Medizinische Kom | System zum einwirken auf, insbesondere zerstoeren von viren |
WO1989001519A1 (en) * | 1987-08-20 | 1989-02-23 | Children's Hospital Corporation | Human mannose binding protein |
CA2017739A1 (en) * | 1989-07-18 | 1991-01-18 | Leslie S. Hollis | Cis-diamineplatinum complexes with methanediphosphonate and substituted methanediphosphonate ligands as antitumor agents |
AU6521790A (en) * | 1989-10-13 | 1991-05-16 | Hans Schreier | Lipophilic acylpyrazinamide prodrugs |
-
1991
- 1991-07-31 DK DK91915386T patent/DK0598719T3/da active
- 1991-07-31 EP EP91915386A patent/EP0598719B1/en not_active Expired - Lifetime
- 1991-07-31 ES ES91915386T patent/ES2123514T3/es not_active Expired - Lifetime
- 1991-07-31 CA CA002114629A patent/CA2114629C/en not_active Expired - Fee Related
- 1991-07-31 AT AT91915386T patent/ATE171072T1/de not_active IP Right Cessation
- 1991-07-31 JP JP51448991A patent/JP3369555B2/ja not_active Expired - Fee Related
- 1991-07-31 WO PCT/US1991/005422 patent/WO1993002709A1/en active IP Right Grant
- 1991-07-31 DE DE69130235T patent/DE69130235T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH06511466A (ja) | 1994-12-22 |
WO1993002709A1 (en) | 1993-02-18 |
DE69130235D1 (de) | 1998-10-22 |
CA2114629C (en) | 2003-01-14 |
EP0598719B1 (en) | 1998-09-16 |
ATE171072T1 (de) | 1998-10-15 |
EP0598719A1 (en) | 1994-06-01 |
ES2123514T3 (es) | 1999-01-16 |
DE69130235T2 (de) | 1999-02-11 |
JP3369555B2 (ja) | 2003-01-20 |
CA2114629A1 (en) | 1993-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO995349L (no) | Multivalent vaksinasjonssammensetning med blandet baerer | |
ES2066603T3 (es) | Fungicidas de 3-difluorometilpirazolcarboxamida. | |
PT688789E (pt) | Processo de lipopeptideos processo para a sua preparacao e sua utilizacao | |
UY26380A1 (es) | Inhibidores de fab i | |
ES2184149T3 (es) | Paclitaxeles 6-tio sustituidos. | |
DK0582829T3 (da) | 9-(Substitueret glycyl)amido-6-demethyl-6-deoxytetracycliner som antibiotiske midler | |
ATE267164T1 (de) | 9-(substituiertes glycyl)amido-6-(substituiert)-5-hydroxy-6-deoxy etracycline | |
MX9204132A (es) | Composiciones farmaceuticas que contienen rifaximin y procedimiento para su preparacion. | |
SE9704545D0 (sv) | Novel compounds | |
SE9704544D0 (sv) | Novel compounds | |
DK58291D0 (da) | Krystalinsk stof og dets fremstilling | |
PT100914A (pt) | Uso de compostos capazes de sofrer uma permuta mista com dissulfureto, com uma ligacao dissulfureto, no tratamento de infeccao por hiv | |
EP0869801A4 (en) | THERAPEUTIC AND DIAGNOSTIC AGENTS FOR TREATING MICROBIAL INFECTIONS | |
BR0109164A (pt) | Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos | |
DK0598719T3 (da) | Receptorkonjugater til destinering af lægemidler og andre midler | |
NZ509051A (en) | Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use | |
DE69936052D1 (de) | N1 modifizierte glycopeptide | |
NO307462B1 (no) | Imidazopyridin-azolidinoner | |
ES2115975T3 (es) | Derivados de triariletileno utilizados terapeuticamente. | |
ATE250340T1 (de) | 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele | |
ES2076107A1 (es) | Derivados de antibioticos macrolidos de anillos de 16 miembros. |